Skip to content

Evaluation and Implementation of Mobile Tracking Devices to Increase Safety in Hospitalized Patients (MONITOR)

Evaluation and Implementation of Mobile Tracking Devices to Increase Safety in Hospitalized Patients - MONITOR 2022

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05418881
Acronym
MONITOR
Enrollment
500
Registered
2022-06-14
Start date
2021-11-01
Completion date
2023-11-01
Last updated
2022-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Fitness Trackers, Hemodynamic Monitoring, Internet of Things, Postoperative Complications, Surgery, Wearable Electronic Devices

Brief summary

The study investigates the technical feasibility of using mobile health trackers for monitoring of hospitalized patients. Therefore the measurement accuracy of several vital parameters in postoperative hospitalized patients will be compared to clinical gold standard. Factors that could have an influence on the measurement accuracy of the mobile sensors will be investigated.Furthermore patient compliance in continous use of mobile health trackers and technical feasibility of needed data flow will be analyzed. In addition, patients' activity levels are recorded and correlated with various clinical parameters.

Interventions

DEVICEMobile Tracking Device (one spot)

Patients will be fitted with 4 different tracking devices (Garmin Fenix 6 Pro®, Apple Watch 7®, FitBit Sense®, Withings ScanWatch®).

DEVICEMobile Tracking Device + Activity Sensor (longitudinal)

Patients will be fitted with 1 of 3 different tracking devices (Garmin Fenix 6 Pro®, Apple Watch 7®, Withings ScanWatch®). The type of tracking device will be randomized. Additionally an Activity Tracker and one-channel ECG (Movesense®) will be worn by the patients.

Sponsors

University of Wuerzburg
CollaboratorOTHER
Wuerzburg University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with elective surgery (≥ 18 years). * Written informed consent to participate in the study * Planned invasive arterial blood pressure measurement

Exclusion criteria

* Postoperative invasive ventilation * American Society of Anaesthesiologists (ASA) Class V * Outpatient surgical procedure * Previous participation in this study * Patients unable to give consent or patients who do not have adequate German language skills * Suspected lack of compliance * Skin lesions of the forearms or inability to wear a tracking device * Known allergy to latex/silicone/nickel

Design outcomes

Primary

MeasureTime frameDescription
Measurement accuracypostoperative until hospital discharge up to 21 daysHeart rate as compared to ECG

Secondary

MeasureTime frameDescription
Postoperative inertial movementpostoperative until hospital discharge up to 21 daysAs measured by an inertial activity sensor (MoveSense®) in inertial measurement units (IMU)
Patient compliance with mobile tracking devicespostoperative until hospital discharge up to 21 daysAs measured by a survey
Postoperative step countpostoperative until hospital discharge up to 21 daysAs measured by tracking devices in steps per day

Countries

Germany

Contacts

Primary ContactPhilipp Helmer, Dr.
helmer_p@ukw.de+49 (931) 201 30574
Backup ContactSebastian Hottenrott
hottenrott_s@ukw.de+49 (931) 201 30563

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026